🧠AI AnalysisAI Assessment: Landmark Clinical Trials Signal a Turning Point for Personalized Cancer Vaccines
Recent phase 3 clinical trials of a personalized melanoma vaccine indicate a major shift in cancer treatment, overcoming decades of historical hurdles in immunotherapy.